• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对于顺铂不耐受的转移性阴茎癌患者，化疗中用卡铂替代顺铂。

Switching cisplatin to carboplatin in chemotherapy for metastatic penile cancer in a patient intolerant to cisplatin.

作者信息

Sekine Keita, Suyama Takahito, Takei Kazuki, Kato Hiroto, Wakai Ken, Okato Atsushi, Hou Kyokushin, Araki Kazuhiro, Yamazaki Kazuto, Naya Yukio

机构信息

Department of Urology Teikyo University Chiba Medical Center Ichihara Chiba Japan.

Present address: Chibaken Saiseikai Narashino Hospital Chiba Japan.

出版信息

IJU Case Rep. 2024 Aug 21;7(6):434-437. doi: 10.1002/iju5.12772. eCollection 2024 Nov.

DOI:10.1002/iju5.12772
PMID:39498186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11531887/
Abstract

INTRODUCTION

Cisplatin is currently the key drug in the chemotherapy regimen for metastatic penile cancer. There are few reports of alternative medicines for patients who cannot tolerate cisplatin. This report describes a case in which carboplatin was used instead.

CASE PRESENTATION

The patient presented with a chief complaint of edema in the groin area. On close examination, penile cancer (cT2-3N3M0 stage IV) with pelvic lymph node metastasis was diagnosed. He was started on chemotherapy with cisplatin (50 mg/m on days 1 and 2), paclitaxel (120 mg/m on day 1), and 5-fluorouracil (1000 mg/m on days 2-5), but he developed acute kidney failure on the 12th day, thought to be caused by cisplatin. Cisplatin was changed to carboplatin, and chemotherapy was continued. He has received nine courses of chemotherapy and is doing well.

CONCLUSION

A case of penile cancer safely and effectively treated with chemotherapy using carboplatin was reported.

摘要

引言

顺铂是目前转移性阴茎癌化疗方案中的关键药物。对于无法耐受顺铂的患者，替代药物的报道较少。本报告描述了一例使用卡铂替代顺铂的病例。

病例介绍

患者以腹股沟区水肿为主诉就诊。经仔细检查，诊断为阴茎癌（IV期，cT2 - 3N3M0）伴盆腔淋巴结转移。他开始接受顺铂（第1天和第2天，50mg/m²）、紫杉醇（第1天，120mg/m²）和5-氟尿嘧啶（第2 - 5天，1000mg/m²）的化疗，但在第12天出现急性肾衰竭，认为是由顺铂引起的。顺铂改为卡铂，并继续化疗。他已接受了九个疗程的化疗，目前情况良好。

结论

报告了一例使用卡铂化疗安全有效地治疗阴茎癌的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/11531887/51cc1beabea5/IJU5-7-434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/11531887/cf66c8292009/IJU5-7-434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/11531887/edc70592dd94/IJU5-7-434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/11531887/cb53e359780f/IJU5-7-434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/11531887/51cc1beabea5/IJU5-7-434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/11531887/cf66c8292009/IJU5-7-434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/11531887/edc70592dd94/IJU5-7-434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/11531887/cb53e359780f/IJU5-7-434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3420/11531887/51cc1beabea5/IJU5-7-434-g001.jpg

相似文献

1
Switching cisplatin to carboplatin in chemotherapy for metastatic penile cancer in a patient intolerant to cisplatin.对于顺铂不耐受的转移性阴茎癌患者，化疗中用卡铂替代顺铂。
IJU Case Rep. 2024 Aug 21;7(6):434-437. doi: 10.1002/iju5.12772. eCollection 2024 Nov.
2
[Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].[化疗对上皮性卵巢癌淋巴结转移的临床疗效分析]
Ai Zheng. 2003 Apr;22(4):424-7.
3
[Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report].[阴茎癌伴腹股沟淋巴结转移对紫杉醇、异环磷酰胺和顺铂新辅助化疗的显著反应：一例报告]
Hinyokika Kiyo. 2015 Jan;61(1):33-7.
4
Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.对于局部晚期食管癌患者，与顺铂/紫杉醇联合治疗相比，新辅助放化疗联合顺铂/5-氟尿嘧啶可提高病理完全缓解率并改善生存率。
Dis Esophagus. 2017 Jul 1;30(7):1-7. doi: 10.1093/dote/dox015.
5
Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer.专家共识：晚期或转移性上皮性卵巢癌的评估和管理。
Rev Colomb Obstet Ginecol. 2024 Jun 14;75(1):4094. doi: 10.18597/rcog.4094.
6
Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.新辅助紫杉醇、异环磷酰胺和顺铂化疗治疗转移性阴茎癌：一项 II 期研究。
J Clin Oncol. 2010 Aug 20;28(24):3851-7. doi: 10.1200/JCO.2010.29.5477. Epub 2010 Jul 12.
7
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.三联疗法与围手术期化疗治疗局部晚期食管及食管胃交界腺癌（Neo - AEGIS）：一项开放标签、随机、3期试验
Lancet Gastroenterol Hepatol. 2023 Nov;8(11):1015-1027. doi: 10.1016/S2468-1253(23)00243-1. Epub 2023 Sep 18.
8
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.国际罕见癌症倡议多中心随机二期试验：顺铂和氟尿嘧啶对比卡铂和紫杉醇治疗晚期肛门癌：InterAAct。
J Clin Oncol. 2020 Aug 1;38(22):2510-2518. doi: 10.1200/JCO.19.03266. Epub 2020 Jun 12.
9
Commentary on "Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?" Mertens LS, Meijer RP, Kerst JM, Bergman AM, van Tinteren H, van Rhijn BW, Horenblas S, Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands: J Urol 2012;188(4):1108-13 [Epub 2012 Aug 15].评论“非局部浸润性膀胱癌的卡铂为基础的诱导化疗——顺铂不耐受患者的合理替代方案？”Mertens LS，Meijer RP，Kerst JM，Bergman AM，van Tinteren H，van Rhijn BW，Horenblas S，荷兰癌症研究所泌尿科，荷兰阿姆斯特丹安东尼范列文虎克医院：J Urol 2012；188（4）：1108-13 [Epub 2012 年 8 月 15 日]。
Urol Oncol. 2013 Jul;31(5):716-7. doi: 10.1016/j.urolonc.2013.03.012.
10
Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical Trial.紫杉烷类加铂类方案与多柔比星加顺铂方案作为高复发风险子宫内膜癌辅助化疗的效果：一项随机临床试验。
JAMA Oncol. 2019 Jun 1;5(6):833-840. doi: 10.1001/jamaoncol.2019.0001.

本文引用的文献

1
Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis.免疫治疗时代卡铂对转移性尿路上皮癌疗效的重新评估：一项系统评价和荟萃分析
Eur Urol Focus. 2022 Nov;8(6):1687-1695. doi: 10.1016/j.euf.2022.02.007. Epub 2022 Mar 9.
2
Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.多西他赛、顺铂和氟尿嘧啶用于远处转移性阴茎癌患者一线化疗的II期研究。
Oncotarget. 2015 Oct 13;6(31):32212-9. doi: 10.18632/oncotarget.4802.
3
Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001).
局部晚期和转移性阴茎癌中多西他赛、顺铂和 5FU 化疗的 II 期临床试验（CRUK/09/001）。
Br J Cancer. 2013 Nov 12;109(10):2554-9. doi: 10.1038/bjc.2013.620. Epub 2013 Oct 29.
4
Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results.紫杉烷联合顺铂和氟尿嘧啶治疗晚期阴茎癌：初步结果
Eur Urol. 2009 Mar;55(3):546-51. doi: 10.1016/j.eururo.2008.07.014. Epub 2008 Jul 14.
5
Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.转移性或局部晚期泌尿生殖系统鳞状细胞癌的联合化疗：甲氨蝶呤、顺铂和博来霉素的II期研究
J Urol. 1998 Nov;160(5):1770-4.
6
Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinoma.新辅助顺铂和干扰素α-2B在阴茎癌治疗及器官保留中的应用
J Urol. 1994 Oct;152(4):1124-6. doi: 10.1016/s0022-5347(17)32520-x.
7
Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer.甲氨蝶呤、顺铂和博来霉素用于阴茎癌的序贯试验。
J Urol. 1984 Sep;132(3):465-8. doi: 10.1016/s0022-5347(17)49693-5.
8
Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis.阴茎鳞状细胞癌腹股沟转移灶的辅助和新辅助长春新碱、博来霉素及甲氨蝶呤治疗
Acta Oncol. 1988;27(6b):823-4. doi: 10.3109/02841868809094366.